| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8221534 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Prior exposure of the liver to EBRT may lead to increased liver toxicity after RE treatment, depending on fractional liver exposure and dose level. The V30 was the strongest predictor of toxicity. RE appears to be safe for the treatment of hepatic malignancies only in patients who have had limited hepatic exposure to prior EBRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Marnix G.E.H. MD, PhD, Mohamed H.K. MD, MS, Daniel T. MD, Neville C. BS, Melody P. BS, Albert C. MD, PhD, John D. MD, Daniel Y. MD, PhD,